Aspirin as good as Plavix for poor leg circulation: study

February 22, 2012 By Steven Reinberg, HealthDay Reporter
Aspirin as good as plavix for poor leg circulation: study
Both work equally well in condition that causes pain while walking.

(HealthDay) -- Aspirin works as well as Plavix in patients with blocked leg arteries, a new European study finds.

People with the condition, called peripheral artery disease, often suffer from intermittent claudication, which is pain while walking because of decreased to the legs. had suggested that aspirin might block the growth of blood vessels that bypass and help get more blood to leg tissue, the Swiss and German researchers said.

"Once again, we have shown that what happens in animals doesn't translate to humans," said Dr. Juan Zambrano, an assistant professor of , coronary/endovascular and stem cell therapies at the University of Miami Miller School of Medicine.

Patients suffering from peripheral artery disease are also at increased risk of heart attack and stroke from blood clots traveling from the legs to the heart or brain, which is why these patients are given such as Plavix () or aspirin, explained Zambrano.

"Either aspirin or Plavix is acceptable as a good to avoid heart attack or stroke in these patients," he said. "A lot of people favor aspirin because it's cheaper."

However, the most interesting part of this study to Zambrano was the role of exercise in improving walking distance and time.

"Something as simple as exercise can help improve claudication," he said. "Exercise is key and it doesn't matter how you treat the underlying condition, exercise is always going to help."

The report was published online Feb. 21 in the journal Cardiovascular and Cerebrovascular Disease.

For the study, a team led by Dr. Kurt Jaeger from University Hospital Basel in Switzerland, looked at the effectiveness of aspirin and Plavix in helping peripheral artery disease patients improve pain-free walking distance, which is a vital part of rehabilitation.

The researchers randomly assigned 229 patients to receive low-dose aspirin or Plavix, to see how they did during one hour walks.

Jaeger's group found that, after 12 weeks, people taking aspirin improved pain-free walking distance almost 40 percent and could walk 35 percent longer before pain made it too hard to continue.

For patients taking , there was a 33 percent improvement in walking distance and an almost 35 improvement in pain-free walking time, the researchers noted.

Walking is an important part of rehabilitation for patients. Walking can help increase blood flow to the legs and promote the growth of tiny blood vessels that help supply the leg with blood and oxygen.

It had been thought that aspirin wouldn't work because its anti-inflammatory properties could block the development of these tiny blood vessels that grow to get blood around the blockage.

"It seems that the anti-inflammatory properties of low-dose aspirin and its inhibiting effects on [the growth of new blood vessels] are not of clinical relevance for rehabilitation programs in intermittent claudication," the researchers concluded.

Explore further: Stopping a daily aspirin routine increases heart attack risk

More information: For more on peripheral artery disease, visit the American Heart Association.

Related Stories

American Heart Association launches free-access online journal

February 21, 2012

The American Heart Association has launched the online-only open-access Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (JAHA) -- packed with free peer-reviewed research on heart disease ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 22, 2012
Neither aspirin is without risks though http://www.foxnew...on-loss/

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.